Literature DB >> 2413071

Biosynthesis of von Willebrand protein by human megakaryocytes.

L A Sporn, S I Chavin, V J Marder, D D Wagner.   

Abstract

Immunofluorescence staining of buffy coat smears from a patient with chronic myelogenous leukemia in accelerated phase showed that approximately 13% of all nucleated cells contained von Willebrand protein and, therefore, appeared to be of megakaryocytic origin. This was confirmed by positive staining with antisera against platelet factor 4 and platelet glycoproteins. Short-term cultures of the buffy coat, which lacked endothelial cells, were metabolically labeled with [35S]methionine, and von Willebrand protein was immunopurified from cell lysates and culture medium. Cultures from this patient synthesized and secreted von Willebrand protein, in contrast with cultures from other patients with leukemia, who lacked circulating megakaryocytes, and from normal volunteers. The subunit composition of the megakaryocytic von Willebrand protein was very similar to that of human umbilical vein endothelial cells. The size of the processed subunit (220 kD) and of the cellular (260 kD) and secreted (275 kD) precursors from the two cell types were indistinguishable by gel electrophoresis. Furthermore, the ratio of precursor to processed subunit and the pattern of cellular and secreted nonreduced multimers were very similar. It appears, therefore, that the processing steps in biosynthesis of von Willebrand protein used by the megakaryocytes are very similar to those of umbilical vein endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413071      PMCID: PMC423998          DOI: 10.1172/JCI112064

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Decreased adhesion of platelets to subendothelium in von Willebrand's disease.

Authors:  T B Tschopp; H J Weiss; H R Baumgartner
Journal:  J Lab Clin Med       Date:  1974-02

Review 2.  The factor VIII complex: structure and function.

Authors:  L W Hoyer
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

3.  Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

4.  Antiheparin proteins secreted by human platelets. purification, characterization, and radioimmunoassay.

Authors:  B Rucinski; S Niewiarowski; P James; D A Walz; A Z Budzynski
Journal:  Blood       Date:  1979-01       Impact factor: 22.113

5.  Similarities and differences between the fibronectins of normal and transformed hamster cells.

Authors:  D D Wagner; R Ivatt; A T Destree; R O Hynes
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

6.  Immunofluorescent identification of human megakaryocyte colonies using an antiplatelet glycoprotein antiserum.

Authors:  E M Mazur; R Hoffman; J Chasis; S Marchesi; E Bruno
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

7.  Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.

Authors:  J Koutts; P N Walsh; E F Plow; J W Fenton; B N Bouma; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.

Authors:  R Nachman; R Levine; E A Jaffe
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

10.  Factor VIII-related antigen in human blood platelets: localization and release by thrombin and collagen.

Authors:  M B Zucker; M J Broekman; K L Kaplan
Journal:  J Lab Clin Med       Date:  1979-11
View more
  66 in total

1.  In silico cloning of novel endothelial-specific genes.

Authors:  L Huminiecki; R Bicknell
Journal:  Genome Res       Date:  2000-11       Impact factor: 9.043

2.  Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis.

Authors:  S Kanaji; S A Fahs; Q Shi; S L Haberichter; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

3.  Translational medicine advances in von Willebrand disease.

Authors:  D Lillicrap
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

4.  Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation.

Authors:  Heidi R Flori; Lorraine B Ware; Meredith Milet; Michael A Matthay
Journal:  Pediatr Crit Care Med       Date:  2007-03       Impact factor: 3.624

Review 5.  Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.

Authors:  Minola Manea; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2008-09-20       Impact factor: 3.714

6.  Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

Authors:  T C Nichols; C M Samama; D A Bellinger; J Roussi; R L Reddick; M Bonneau; M S Read; O Bailliart; G G Koch; M Vaiman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 7.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

8.  Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

Authors:  Sandra L Haberichter; Elizabeth P Merricks; Scot A Fahs; Pamela A Christopherson; Timothy C Nichols; Robert R Montgomery
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

9.  A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning.

Authors:  Márcia B Silva; Mirta Schattner; Celso R R Ramos; Inácio L M Junqueira-de-Azevedo; Míriam C Guarnieri; María A Lazzari; Claudio A M Sampaio; Roberto G Pozner; Janaina S Ventura; Paulo L Ho; Ana M Chudzinski-Tavassi
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

10.  The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.

Authors:  Natalia Rydz; Laura L Swystun; Colleen Notley; Andrew D Paterson; J Jacob Riches; Kate Sponagle; Boonchai Boonyawat; Robert R Montgomery; Paula D James; David Lillicrap
Journal:  Blood       Date:  2013-03-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.